Short Interest in Celularity Inc. (NASDAQ:CELUW) Grows By 350.4%

Celularity Inc. (NASDAQ:CELUW) was the target of a large increase in short interest in the month of April. As of April 30th, there was short interest totaling 3,342 shares, an increase of 350.4% from the April 15th total of 742 shares. Based on an average daily volume of 7,256 shares, the days-to-cover ratio is presently 0.5 days.

Celularity Stock Up 18.2%

Shares of NASDAQ CELUW traded up $0.00 during midday trading on Thursday, hitting $0.01. 167 shares of the company’s stock were exchanged, compared to its average volume of 17,465. Celularity has a 12-month low of $0.01 and a 12-month high of $0.08. The business’s fifty day moving average price is $0.01 and its two-hundred day moving average price is $0.01.

Celularity Company Profile

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.